Venture Visionary Partners LLC Organon & Co. Transaction History

Venture Visionary Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.45 - $21.96 $189,454 - $238,419	10,857 New	10,857 $224,000
Q3 2023 Oct 13, 2023	BUY	$16.59 - $23.77 $69,445 - $99,501	4,186 Added 7.76%	58,097 $1.01 Million
Q2 2023 Jul 14, 2023	BUY	$19.27 - $24.63 $1.04 Million - $1.33 Million	53,911 New	53,911 $1.12 Million
Q2 2022 Jul 26, 2022	BUY	$31.66 - $38.9 $117,806 - $144,746	3,721 New	3,721 $125,000
Q1 2022 May 03, 2022	SELL	$30.45 - $39.36 $204,471 - $264,302	-6,715 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$28.67 - $37.13 $4,701 - $6,089	-164 Reduced 2.38%	6,715 $204,000
Q3 2021 Oct 20, 2021	BUY	$28.63 - $35.64 $2,433 - $3,029	85 Added 1.25%	6,879 $225,000
Q2 2021 Aug 05, 2021	BUY	$28.45 - $38.0 $193,289 - $258,172	6,794 New	6,794 $205,000

797

202M

1.45M

870K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.83B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Venture Visionary Partners LLC with notifications on news.